VAZ-DE-MACEDO, Carolina    CLODE, Nuno. sFlt-1/PlGF ratio as a predictor of pre-eclampsia in the second and third trimesters of pregnancy: is clinical use supported by the evidence?. []. , 11, 2, pp.76-79. ISSN 1646-5830.

Pre-eclampsia is a common and potentially serious disorder of pregnancy. An antiangiogenic state appears to be central to its development. In particular, the sFlt-1/PlGF ratio increases in pre-eclampsia, leading to its potential use as a marker for prediction and diagnosis. Immunoassays for the sFlt-1/PlGF ratio are now commercially available and can assist in the diagnosis of women with a clinical suspicion of pre-eclampsia, leading to a decrease in hospital admissions. Remarkably, information is missing on the impact of its use in pregnancy outcomes

: Preeclampsia; Diagnosis; Placenta growth factor; Soluble vascular endothelial growth; Factor receptor-1; human; Decision support techniques.

        · |     · ( pdf )